CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 51 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $616 | -45.0% | 421,743 | -13.9% | 0.00% | -50.0% |
| Q2 2023 | $1,121 | +143.7% | 489,673 | -3.2% | 0.00% | +100.0% |
| Q1 2023 | $460 | -16.5% | 506,032 | -22.0% | 0.00% | 0.0% |
| Q4 2022 | $551 | -99.9% | 648,632 | -33.5% | 0.00% | 0.0% |
| Q3 2022 | $798,000 | -16.3% | 975,519 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $953,000 | -35.5% | 962,932 | +6.9% | 0.00% | -50.0% |
| Q1 2022 | $1,478,000 | -41.2% | 901,132 | -13.7% | 0.00% | -33.3% |
| Q4 2021 | $2,515,000 | -15.4% | 1,043,732 | +69.9% | 0.00% | -25.0% |
| Q3 2021 | $2,974,000 | +69.3% | 614,370 | -6.6% | 0.00% | +100.0% |
| Q2 2021 | $1,757,000 | -14.0% | 658,070 | -0.8% | 0.00% | -33.3% |
| Q1 2021 | $2,043,000 | -28.0% | 663,470 | -16.8% | 0.00% | 0.0% |
| Q4 2020 | $2,838,000 | -19.1% | 797,070 | -8.9% | 0.00% | -25.0% |
| Q3 2020 | $3,509,000 | +25.0% | 875,000 | -15.2% | 0.00% | +100.0% |
| Q2 2020 | $2,807,000 | +42.9% | 1,031,900 | +10.9% | 0.00% | 0.0% |
| Q1 2020 | $1,964,000 | -60.2% | 930,700 | +2.7% | 0.00% | -50.0% |
| Q4 2019 | $4,930,000 | +92.3% | 906,200 | +6.4% | 0.00% | +100.0% |
| Q3 2019 | $2,564,000 | -17.7% | 851,778 | +2.2% | 0.00% | -33.3% |
| Q2 2019 | $3,116,000 | -0.8% | 833,098 | +6.6% | 0.00% | 0.0% |
| Q1 2019 | $3,142,000 | +29.2% | 781,700 | +18.0% | 0.00% | 0.0% |
| Q4 2018 | $2,431,000 | -28.6% | 662,300 | +66.9% | 0.00% | -25.0% |
| Q3 2018 | $3,405,000 | -59.9% | 396,900 | -47.2% | 0.00% | -20.0% |
| Q2 2018 | $8,487,000 | +72.5% | 751,600 | +76.1% | 0.01% | 0.0% |
| Q1 2018 | $4,920,000 | +102.8% | 426,700 | +82.2% | 0.01% | +66.7% |
| Q4 2017 | $2,426,000 | -21.7% | 234,200 | +20.5% | 0.00% | -25.0% |
| Q3 2017 | $3,097,000 | +86.7% | 194,300 | +41.7% | 0.00% | +100.0% |
| Q2 2017 | $1,659,000 | +38.1% | 137,100 | +137.2% | 0.00% | 0.0% |
| Q1 2017 | $1,201,000 | – | 57,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |